Ono Pharmaceutical Co., Ltd. $4528.T
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS20
PHASE 3 / 2-38
RECRUITING11
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO15%
Delay Index: of 13 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →
Open Ono Pharmaceutical Co., Ltd. on the live radar map → 📅 $4528.T readout calendar (.ics)| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| ONO-2808 NCT05923866 |
P2 | Active, not recruiting | Multiple System Atrophy (MSA) | 92 | 2025-09-15 |
| ONO-4578 NCT06256328 |
P2 | Active, not recruiting | Gastric Cancer | 226 | 2025-10-09 (-2 mo) |
| ONO-4538 NCT05144854 |
P3 | Active, not recruiting | Gastric Cancer | 626 | 2025-10-20 (-15 mo) |
| Tirabrutinib NCT04947319 |
P2 | Active, not recruiting | Refractory Primary Central Nervous System Lymphoma; Primary CNS Lymphoma | 119 | 2026-01-27 (+20 mo) |
| ONO-2020 NCT06803823 |
P2 | Recruiting | Agitation Associated With Alzheimer's Disease Dementia | 90 | 2026-12-31 |
| Cenobamate NCT06579573 |
P3 | Recruiting | Epilepsy, Generalized | 15 | 2027-01-31 |
| Cenobamate NCT06590896 |
P2 | Recruiting | Epilepsies, Partial | 100 | 2027-01-31 |
| ONO-4059 NCT06696716 |
P3 | Active, not recruiting | Pemphigus; Steroid-resistant Pemphigus | 34 | 2027-09-30 |
| IGNITE NCT07104032 |
P3 | Recruiting | Relapsed/Refractory Primary Central Nervous System Lymphoma | 132 | 2027-12 |
| ONO-4538 NCT04566380 |
P2 | Recruiting | Pan-tumor | 70 | 2027-12-31 (+27 mo) |
| ONO-4578 NCT06948448 |
P2 | Recruiting | Colorectal Cancer | 144 | 2028-02-15 |
| Cenobamate (tablet) for 12 to < 18 year olds NCT07594158 |
P3 | Recruiting | Partial Epilepsy | 20 | 2028-03-30 |
| DCC-3014 NCT07832747 |
P2 | Not yet recruiting | Tenosynovial Giant Cell Tumor | 18 | 2028-08-31 |
| INTREPID NCT07429266 |
P3 | Recruiting | Polycythemia Vera | 250 | 2028-09 |
| ONO-4538 NCT06622941 |
P2 | Recruiting | Rhabdoid Tumor | 23 | 2029-01-31 |
| ONO-4915 NCT07823790 |
P2 | Not yet recruiting | Sjogren's Disease | 60 | 2029-02 |
| ONO-4538 NCT06936943 |
P2 | Recruiting | Richter's Transformation | 14 | 2029-07-31 |
| ONO-2808 NCT07825402 |
P3 | Not yet recruiting | Multiple System Atrophy, Parkinson Variant | 486 | 2029-10 |
| ONO-4538HSC NCT07734116 |
P1/2 | Recruiting | Pediatric Malignant Solid Tumor and Epithelioid Sarcoma | 50 | 2029-11-30 |
| ONO-4578 NCT07818070 |
P3 | Not yet recruiting | Gastric Cancer; Esophagogastric Junction Cancer | 600 | 2031-01 |